🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for revolutionary findings that illuminate how the immune system attacks dangerous infections while sparing the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this honor.

Their work uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells that could harming the body.

These findings are now paving the way for new therapies for immune disorders and malignancies.

These laureates will divide a monetary award valued at 11 million Swedish kronor.

Crucial Discoveries

"The work has been essential for comprehending how the immune system functions and why we do not all develop severe autoimmune diseases," stated the head of the Nobel Committee.

This team's research address a fundamental mystery: In what way does the defense system protect us from numerous infections while keeping our own tissues unharmed?

Our body's protection system uses white blood cells that scan for signs of disease, even pathogens and bacteria it has never encountered.

These cells employ detectors—known as receptors—that are generated by chance in a vast number of variations.

This provides the defense network the ability to fight a broad range of threats, but the unpredictability of the process unavoidably produces immune cells that may target the host.

Security Guards of the Immune System

Scientists earlier understood that a portion of these problematic white blood cells were eliminated in the thymus—the site where white blood cells develop.

This year's Nobel Prize honors the identification of T-reg cells—described as the body's "security guards"—which travel through the body to disarm any immune cells that attack the healthy cells.

It is known that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.

The Nobel panel stated, "These discoveries have established a new field of investigation and spurred the creation of innovative therapies, for instance for tumors and immune disorders."

Regarding malignancies, T-regs block the system from attacking the growth, so studies are focused on reducing their quantity.

In autoimmune diseases, trials are testing boosting T-reg cells so the organism is no longer being harmed. A similar method could also be useful in minimizing the risks of transplanted organ failure.

Pioneering Studies

Professor Sakaguchi, of Osaka University, performed tests on mice that had their thymus removed, leading to self-attack conditions.

The researcher demonstrated that introducing defense cells from healthy mice could stop the illness—suggesting there was a system for preventing immune cells from harming the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in rodents and humans that resulted in the discovery of a gene vital for the way regulatory T-cells operate.

"The groundbreaking work has revealed how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the body's own tissues," commented a prominent physiology specialist.

"The work is a striking example of how basic biological study can have broad consequences for human health."